NFKB1 and glioblastoma: β-caryophyllene is a natural CB2 receptor agonist that potentially inhibits cell survival proteins [11] and also modulates the activation of NFκB and PPARγ; thus, it has been tested to reduce proliferation and activate apoptosis in glioblastoma.